Executive Summary
This digest covers 50 filings from July 7, 2026, dominated by corporate restructuring, insolvency, and M&A activity across Indian and US markets. A key theme is the surge in Indian insolvencies (CIRP) and regulatory actions, with 6 companies in various stages of resolution, signaling persistent stress in the Indian corporate sector.
Concurrently, there is significant M&A activity, including high-value deals like GSK's $10.3B acquisition of Nuvalent and the Torrent/JB Chemicals amalgamation, alongside numerous smaller strategic acquisitions and divestitures. The US SPAC market shows renewed activity with two new IPOs (Osprey Acquisition Corp. III and Viking Acquisition Corp. II) and one extension filing, indicating a potential thaw in the blank-check sector. Notable negative events include a major default by BGR Energy Systems (₹4,091 crore) and the delisting of Olaplex Holdings, highlighting ongoing credit and compliance risks. Insider activity was limited but included a promoter stake increase in Getalong Enterprise, providing a mildly bullish signal.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · Schedule 13D
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from July 06, 2026.
Investment Signals (11)
- GSK plc / Nuvalent▲
GSK's $124/share cash offer ($10.3B equity value) represents a 66% premium over the low end of Centerview's valuation range ($74.50), signaling strong strategic value. The HSR waiting period expires July 9, 2026, making this a near-term catalyst. [BULLISH for GSK's pipeline, NEUTRAL for Nuvalent as deal is priced]
- PVP Ventures ↓ (BULLISH)▲
Completed second tranche of acquisition in 7 Med India, increasing stake to 41.23%. Total outlay of ~₹127 Cr for majority control in a top-5 organized renal care player. This is a strategic pivot into high-growth healthcare with a clear path to majority control.
- SER Industries (Desi Farms) (BULLISH)▲
Acquired 73.66% of SNA Milk and 62.67% of DFSU Farmer Connect via share swap (~₹49.36 Cr cost). This is a transformative related-party transaction into the dairy sector, leveraging a registered valuer's report, which could unlock significant value if synergies are realized.
- CareDx ↓ (BULLISH)▲
Completed sale of Lab Products business for $171.2M cash, sharpening focus on high-growth U.S. Precision Medicine Testing. The divestiture simplifies the model and provides capital for specialty oncology expansion. Pro forma results expected on Q2 2026 earnings call.
- Glimpse Group ↓ (BULLISH)▲
Sold non-core Glimpse Learning to become a pureplay Physical AI infrastructure company. Focus on Brightline's SpatialCore platform (used by US Navy/Army) and a $1.85M capital infusion earlier this year signal a high-conviction strategic pivot.
- Getalong Enterprise ↓ (BULLISH)▲
Promoter Westpac Investments acquired 2,40,000 shares at ₹7.56/share via open market, increasing stake from 41.94% to 43.07%. This insider buying at a low absolute price suggests management confidence in the company's prospects.
- BGR Energy Systems ↓ (BEARISH)▲
Total default of ₹4,091 crore on bank loans, representing 100% of such facilities. With total financial indebtedness of ₹4,524 crore, the company is in severe financial distress with a high probability of insolvency or restructuring.
- Olaplex Holdings ↓ (BEARISH)▲
Received a delisting notice from Nasdaq effective July 7, 2026, for failure to meet continued listing standards. This is a terminal event for equity holders, as the stock will no longer trade on a major exchange.
- Compuage Infocom ↓ (BEARISH)▲
CIRP continues, with the 26th CoC meeting failing to approve a resolution for distribution of funds. The inability to distribute funds signals ongoing creditor disputes and a prolonged resolution process, which is negative for recovery prospects.
-
Reports zero revenue, a net loss of ₹4.68 Lakhs, and negative net worth of ₹664 Lakhs. The proposed amalgamation with Invade Agro (5:2 share swap) is a rescue merger for a company with no operating business. [BEARISH for Chambal equity]
- Banzai International / ConnectAndSell ↓ (BEARISH)▲
Potential acquisition target shows 9.2% YoY revenue decline and a widening net loss to ($3.1M) from ($0.1M). Despite positive operating cash flow, the accumulated deficit of $57.6M and going concern opinion are major red flags.
Risk Flags (10)
- BGR Energy Systems / Credit Risk↓ [HIGH RISK]▼
Total default of ₹4,091 crore on bank loans (100% of outstanding). With total debt of ₹4,524 crore, the company is effectively insolvent. Bondholders of unlisted NCDs/NCRPS (₹433 crore) face potential contagion risk if the situation worsens.
- Olaplex Holdings / Delisting↓ [HIGH RISK]▼
Nasdaq delisting effective immediately. The stock loses access to major exchange liquidity, index inclusion, and institutional investor base. This is a catastrophic event for equity holders.
- Hira Automobiles / Regulatory Non-Compliance↓ [HIGH RISK]▼
A delisting process initiated in 2013 remains unresolved after 13 years. SEBI imposed a ₹14 Lakh penalty for non-filing of compliance reports. The company is now seeking directions to meet minimum public shareholding norms, indicating deep-rooted governance issues.
- Siti Networks / Insolvency↓ [MEDIUM RISK]▼
CIRP has been ongoing since February 2023 (over 3 years). While a new auditor was appointed, the prolonged process suggests a complex or contentious resolution, increasing the risk of liquidation.
- Future Lifestyle Fashions / Insolvency↓ [MEDIUM RISK]▼
CIRP initiated in May 2023 (over 3 years). The 38th CoC meeting with no disclosed progress on a resolution plan indicates a stalled process, typical of highly leveraged retail companies.
- Impex Ferro Tech / Insolvency↓ [MEDIUM RISK]▼
29th CoC meeting held with no disclosed outcomes. The Resolution Professional's mandate runs until Dec 30, 2026, but the lack of progress after 29 meetings signals a challenging resolution.
- Mercantile Ventures / Credit Quality↓ [MEDIUM RISK]▼
Regional Director flagged loans and advances with irregular repayment and an expected credit loss provision of ₹337.16 Lakh. This credit quality issue within the acquirer could impair the merged entity's financial health.
- Kkalpana Plastick / Change in Control↓ [MEDIUM RISK]▼
A complete change in control with promoters selling 72.58% stake to a new investor with no prior relationship. While the open offer provides an exit at ₹28/share, the new management's strategy is unknown, creating execution risk.
- Shorepower Technologies / Opaque Transaction↓ [HIGH RISK]▼
Filed an 8-K for an acquisition with a change in control but disclosed zero financial details. The use of unregistered equity (Item 3.02) suggests potential shareholder dilution. The lack of transparency is a major red flag.
- ConnectAndSell / Going Concern [HIGH RISK]▼
The target of Banzai's potential acquisition has an accumulated deficit of $57.6M and a going concern opinion. Revenue declined 9.2% YoY, and net loss widened 29x. This is a distressed asset.
Opportunities (10)
- GSK plc / Nuvalent Acquisition (OPPORTUNITY)◆
GSK's $124/share all-cash offer for Nuvalent creates an arbitrage opportunity. The HSR waiting period expires July 9, 2026. With 11 demand letters filed but no lawsuits, the deal risk is low, offering a potential ~1-2% annualized return for a short holding period.
- PVP Ventures / Healthcare Pivot↓ (OPPORTUNITY)◆
Acquiring majority control (50.62% for ~₹127 Cr) in 7 Med India, a top-5 organized renal care player. This provides exposure to India's growing dialysis market. The phased acquisition structure allows for risk management.
- CareDx / Strategic Refocus↓ (OPPORTUNITY)◆
Post-divestiture of Lab Products for $171.2M, CareDx is a pure-play on U.S. Precision Medicine Testing. The cash infusion supports investment in high-growth specialty oncology. Q2 2026 earnings call will provide pro forma details, a potential catalyst.
- Glimpse Group / Physical AI Pureplay↓ (OPPORTUNITY)◆
The sale of non-core assets and focus on Brightline's SpatialCore platform (used by US Navy/Army) positions the company in the high-growth Physical AI sector. The $1.85M capital infusion and new CEO/board signal a fresh start.
- Osprey Acquisition Corp. III / New SPAC IPO↓ (OPPORTUNITY)◆
A $261M SPAC focused on disruptive energy and AI technologies. With Cantor Fitzgerald as lead underwriter, the sponsor has a strong track record. Investors can participate in the IPO or wait for a business combination target.
- Viking Acquisition Corp. II / New SPAC IPO↓ (OPPORTUNITY)◆
A $200M SPAC with Cohen & Company as underwriter. The $11.50 warrant exercise price provides a potential levered play on a future business combination.
- Torrent Pharmaceuticals / JB Chemicals Merger↓ (OPPORTUNITY)◆
NCLT approval received for the amalgamation. This creates a larger, more diversified pharma entity with potential cost and revenue synergies. The merger is a key catalyst for Torrent's growth.
- Cochin Shipyard / OFS Oversubscription↓ (OPPORTUNITY)◆
The government exercised the full oversubscription option, doubling the OFS size to 5.04% of paid-up capital. Retail investors can participate on July 8, 2026. The strong government interest may signal confidence in the company's prospects.
- Kkalpana Plastick / Open Offer Arbitrage↓ (OPPORTUNITY)◆
The open offer at ₹28/share provides a cash exit for existing shareholders. With the acquirer buying a 72.58% controlling stake, the offer is likely to be successful, providing a near-term arbitrage opportunity if the stock trades at a discount.
- Winro Commercial / Adani QIP Participation↓ (OPPORTUNITY)◆
Invested ~₹100 Cr in Adani Enterprises' QIP at ₹2,883/share. This provides exposure to Adani's diversified conglomerate at the QIP price, which is typically at a discount to market.
Sector Themes (5)
- Indian Corporate Distress Wave◆
6 filings involve companies under CIRP (Siti Networks, Future Lifestyle, Impex Ferro Tech, Compuage Infocom) or in severe financial distress (BGR Energy with ₹4,091 Cr default, Chambal Breweries with negative net worth). This indicates a sustained period of stress in the Indian corporate sector, particularly in manufacturing and retail, with limited resolution progress. [BEARISH for Indian credit markets]
- Pharma & Healthcare Consolidation◆
Two major M&A events (GSK/Nuvalent for $10.3B and Torrent/JB Chemicals) alongside strategic pivots (PVP Ventures into renal care, CareDx refocusing on precision medicine) signal a wave of consolidation and strategic realignment in the healthcare sector, driven by the need for scale and focus on high-growth areas. [BULLISH for pharma M&A]
- SPAC Market Revival◆
Two new SPAC IPOs (Osprey Acquisition Corp. III at $261M and Viking Acquisition Corp. II at $200M) and one extension filing (Launch One Acquisition Corp.) suggest a potential revival in the blank-check market after a prolonged downturn. Focus areas include energy tech, AI, and sustainable infrastructure. [BULLISH for SPAC sponsors]
- Regulatory Scrutiny Intensifies◆
SEBI issued multiple enforcement actions, including an insider trading adjudication order (RHI Magnesita India), recovery proceedings (Austral Coke case), and a penalty for non-compliance (Hira Automobiles). This highlights heightened regulatory vigilance in Indian markets. [BEARISH for companies with weak compliance]
- Strategic Divestitures for Focus◆
Multiple companies are selling non-core assets to sharpen focus: CareDx (Lab Products), Glimpse Group (Glimpse Learning), and MacroGenics (manufacturing ops). This trend suggests a market preference for pure-play companies with clear growth narratives. [BULLISH for focused companies]
Watch List (8)
- GSK plc / Nuvalent👁
HSR waiting period expires July 9, 2026. Watch for a Second Request or early termination. Deal completion expected in Q3 2026. [Date: July 9, 2026]
-
Retail participation on July 8, 2026. Watch for subscription levels and pricing. The government's full oversubscription is a positive signal. [Date: July 8, 2026]
-
The 26th CoC meeting failed to approve fund distribution. Watch for the next CoC meeting and any resolution plan filings. The prolonged process is a negative signal for creditors. [Date: Ongoing]
-
Watch for any restructuring announcements, insolvency filings by creditors, or further defaults on unlisted debt securities. The ₹4,091 Cr default is a critical event. [Date: Ongoing]
-
Watch for any appeal or alternative listing plans. The stock is now effectively illiquid on major exchanges. [Date: Effective July 7, 2026]
-
EGM to vote on extending the business combination deadline from July 15, 2026 to Jan 15, 2027. Failure to approve could lead to liquidation. [Date: Before July 15, 2026]
-
Company will provide pro forma financial details post-divestiture. Watch for updated guidance on core Precision Medicine Testing growth and capital allocation plans. [Date: Q2 2026 earnings call]
-
Open offer for 26% shares at ₹28/share. Watch for subscription levels and the new management's strategic plans post-acquisition. [Date: Open offer period TBD]
Filing Analyses
(50)
07-07-2026
Mercantile Ventures Limited (Transferee) has received NCLT Chennai approval for its amalgamation with India Radiators Limited (Transferor), with an appointed date of 1 January 2025. The scheme aims to reduce administrative and operational costs, eliminate duplication, and enhance overall business efficiency. However, the Regional Director noted that the Transferee Company has loans and advances where repayment of principal and interest is not as stipulated, with an expected credit loss provision of Rs.337.16 Lakh.
- · The appointed date for the scheme is 1 January 2025.
- · Share exchange ratio: 10 equity shares of Mercantile Ventures (face value ₹10 each) for every 36 equity shares of India Radiators (face value ₹10 each).
- · The Transferor Company (India Radiators) will be dissolved without winding up upon effectiveness.
- · The amalgamation will be accounted using the pooling of interest method under Ind AS 103.
- · No inquiry, inspection, investigation, complaint, or prosecution is pending against either company as per ROC report.
- · The scheme will become effective upon filing the certified copy of the NCLT order with the Registrar of Companies, Chennai.
07-07-2026
India Radiators Ltd (Transferor) has received NCLT Chennai approval for its amalgamation with Mercantile Ventures Ltd (Transferee), with an appointed date of 1 January 2025. The scheme, which was approved by shareholders with overwhelming majorities (99.997% of Transferor equity shareholders and 100% of Transferee unsecured trade creditors voting in favor), aims to reduce administrative costs and create operational synergies. However, the Regional Director noted that the Transferee Company has certain loans where repayment is not as stipulated, with Rs.3,32.77 lakh in irregular loans and Rs.337.16 Lakh provided as expected credit loss, indicating credit quality concerns.
- · The appointed date for the scheme is 1 January 2025.
- · The scheme will become effective upon filing the certified copy of the NCLT order with the Registrar of Companies, Chennai.
- · Share exchange ratio: 10 equity shares of Transferee Company (face value ₹10 each) for every 36 equity shares of Transferor Company (face value ₹10 each).
- · The Transferor Company will be dissolved without winding up upon effectiveness.
- · Accounting will follow the pooling of interest method under Ind AS 103.
- · No inquiry, inspection, investigation, complaint, or prosecution is pending against either company as per ROC report dated 04.05.2026.
- · Both companies have filed financial statements and annual returns up to 31.03.2025.
07-07-2026
Yoga Builders Private Limited, Scaffold Properties Private Limited, and MDK Properties and Estates Private Limited (formerly MK Profinlease Private Limited) have announced an open offer to acquire up to 12,87,988 equity shares (26.00% of the fully paid-up voting capital) of TMT (India) Limited at ₹10 per share. The offer opens on July 8, 2026 and closes on July 21, 2026, with the Independent Directors Committee deeming the offer price justified. No competitive bid has been received.
- · The Detailed Public Statement was published on April 27, 2026 in Financial Express (English), Jansatta (Hindi), Pratahkal (Marathi), and Mana Telangana (Telugu).
- · The Draft Letter of Offer was submitted to SEBI on May 5, 2026; SEBI's final observations were received on June 19, 2026.
- · Dispatch of the Letter of Offer to all public shareholders was completed on June 30, 2026.
- · The Identified Date for determining shareholders eligible to receive the Letter of Offer is June 23, 2026.
- · The offer is being made to all public shareholders except the Acquirers, Sellers, and Promoter & Promoter Group.
- · The Manager to the Offer is Navigant Corporate Advisors Limited (SEBI Reg. No. INM000012243).
07-07-2026
Smart Services Private Limited completed an open offer to acquire up to 64,86,000 equity shares (25.00%) of Sharp India Limited at ₹10 per share. However, only 101 shares were tendered and accepted, resulting in the acquirer holding 75.0004% post-offer (via a separate share purchase agreement for 1,94,58,000 shares), while public shareholders retained 24.9996% of the fully diluted equity. The offer was open from June 16 to June 30, 2026, and consideration was paid on July 6, 2026.
- · The open offer was open from June 16, 2026 to June 30, 2026.
- · Consideration was paid on July 6, 2026.
- · The post-offer advertisement was published on July 7, 2026 in Financial Express (English), Jansatta (Hindi), Navshakti (Marathi Mumbai), and Loksatta (Marathi Pune).
- · The acquirer will become the promoter of Sharp India Limited; the existing promoter will be reclassified as public category shareholder under Regulation 31A(10) of SEBI LODR.
- · The manager to the offer is Navigant Corporate Advisors Limited (SEBI Reg. No. INM000012243).
07-07-2026
BGR Energy Systems Limited disclosed a total default of ₹4091.09 crore on loans and revolving facilities from banks/financial institutions as of June 30, 2026, representing the full outstanding amount of such facilities. The company's total financial indebtedness stood at ₹4524.27 crore, with no defaults on unlisted debt securities (NCDs and NCRPS). This disclosure highlights severe financial distress, as the entire loan/revolving facility balance is in default.
- · No defaults on unlisted debt securities (NCDs and NCRPS) as of 30.06.2026.
- · Total financial indebtedness of ₹4524.27 crore exceeds the defaulted loan amount by ₹433.18 crore, indicating additional debt beyond the defaulted facilities.
07-07-2026
Purohit Construction Ltd has incorporated a new Limited Liability Partnership (LLP) named 'PEB PCL INFRACON LLP' on July 6, 2026, with a total contribution of ₹1,00,000. The company will contribute ₹51,000 (51%) and is entitled to 51% of profits and losses, with Joint Managing Director Mr. Saumil Narendrabhai Purohit as its nominee. This is a relatively small investment with no immediate financial impact, and no negative or flat metrics are present.
- · LLP incorporated under the Limited Liability Partnership Act, 2008 on July 6, 2026
- · LLPIN: ACZ-8157
- · Business purpose: prefabricated constructions, construction projects, etc.
- · Company Secretary Nishit Sandhani (M.No- F13357) signed the filing
07-07-2026
Siti Networks Limited, undergoing Corporate Insolvency Resolution Process (CIRP) since February 2023, has appointed M/s. Vijaya Gupta & Co. as its new statutory auditor for FY2025-26 and FY2026-27, replacing M/s. DNS & Associates who resigned. The change was approved by the Committee of Creditors under Section 28(1)(m) of the Insolvency and Bankruptcy Code, 2016, effective July 6, 2026.
- · CIRP was initiated by an NCLT Mumbai order dated February 22, 2023.
- · The new auditor will conduct statutory audits for FY2025-26 and FY2026-27, and limited reviews for Q3 & Q4 FY2025-26 and Q1 to Q4 FY2026-27.
- · Vijaya Gupta & Co. has over 45 years of experience and specializes in banking, corporate, and regulatory domains.
- · No relationship exists between the new auditor and any director of the company (director powers are suspended).
07-07-2026
K.M. Sugar Mills Limited has published newspaper advertisements on July 7, 2026, giving notice of a hearing before the National Company Law Tribunal (NCLT), Allahabad Bench, regarding a Scheme of Arrangement for Demerger between K.M. Sugar Mills (Demerged Company) and KM Spirits And Allied Industries Limited (Resulting Company). The hearing follows an NCLT order dated June 11, 2026, and the advertisements were placed in Financial Express (English) and Jan Satta (Hindi) as required under SEBI Listing Regulations. No financial details of the demerger or any performance metrics are disclosed in this filing.
- · The NCLT order was passed on June 11, 2026.
- · Advertisements were published on July 7, 2026, in Financial Express (English) and Jan Satta (Hindi).
- · The demerger is between K.M. Sugar Mills Limited (Demerged Company) and KM Spirits And Allied Industries Limited (Resulting Company).
- · The filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015.
- · The advertisements are also available on the company's website at https://www.kmsugar.com/scheme-of-arrangement-for-demerger/.
07-07-2026
Future Lifestyle Fashions Limited, undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code 2016, held its 38th Committee of Creditors (CoC) meeting on July 6, 2026. The meeting was convened by Resolution Professional Ravi Sethia, appointed by the NCLT Mumbai Bench on May 4, 2023. No financial results, operational updates, or period-over-period comparisons were disclosed in this filing.
- · The CIRP was initiated by NCLT Mumbai Bench II on May 4, 2023, under CP(IB) No. 959/MB/2022.
- · Ravi Sethia was confirmed as Resolution Professional in the first CoC meeting on June 6, 2023.
- · The company's registered office is at 1st Floor, Future Group Office, SOBO Brand Factory, Mumbai.
- · The filing includes debt scrip code 957150 on BSE.
07-07-2026
Launch One Acquisition Corp. issued 5,749,999 Class A ordinary shares to its sponsor upon conversion of Class B shares on July 6, 2026, leaving 28,749,999 Class A shares outstanding. The company is also pursuing an extension of its business combination deadline from July 15, 2026 to January 15, 2027, and plans to enter non-redemption agreements with shareholders to increase the likelihood of approval and preserve trust account funds. The filing does not provide financial performance data, but the extension effort highlights ongoing challenges in completing a merger within the original timeframe.
- · The conversion was exempt from registration under Section 3(a)(9) of the Securities Act.
- · The Class A shares issued are subject to the same restrictions as the prior Class B shares, including transfer restrictions, waiver of redemption rights, and an obligation to vote in favor of an initial business combination.
- · The EGM is scheduled to vote on the Extension Amendment Proposal; shareholders of record as of May 15, 2026 were mailed the proxy statement on or about June 12, 2026.
- · Non-Redemption Agreements will terminate upon failure of shareholders to approve the extension, fulfillment of obligations, company liquidation/dissolution, mutual agreement, or if an investor exercises redemption rights or fails to vote in favor.
07-07-2026
FortuneX Acquisition Corporation entered into Amendment No. 1 to its Underwriting Agreement on July 1, 2026, revising terms related to its IPO, including firm and option units, deferred underwriting discount, private placement units, and administrative services. The amendment involves Polaris Advisory Partners (representative of the underwriters) and Kingswood Capital Partners LLC. No financial figures or performance metrics were disclosed in this filing.
- · Amendment No. 1 to the Underwriting Agreement was dated July 1, 2026, and filed as Exhibit 10.1.
- · The original Underwriting Agreement was dated May 21, 2026.
- · The amendment revises provisions regarding Firm Units, Option Units, deferred underwriting discount, private placement units, administrative services, offering expenses, Representative's right of first refusal, and trust account acknowledgements.
- · The filing includes a Cover Page Interactive Data File (Inline XBRL).
07-07-2026
Impex Ferro Tech Limited, currently under Corporate Insolvency Resolution Process (CIRP), held its 29th Committee of Creditors (CoC) meeting on 6th July 2026. The filing provides post-facto intimation of the meeting to stock exchanges; however, no specific outcomes, financial figures, or updates on the resolution process were disclosed in this letter.
- · The company remains under Corporate Insolvency Resolution Process (CIRP).
- · Resolution Professional Ashok Kumar Sarawagi is authorized for assignment until December 30, 2026.
- · No specific resolutions or financial outcomes from the 29th CoC meeting were disclosed in this filing.
07-07-2026
Ekam Leasing & Finance Co. Ltd. has fixed July 17, 2026 as the record date for an NCLT-directed meeting of equity shareholders to vote on a proposed Scheme of Amalgamation. Remote e-voting will run from July 20 to July 23, 2026. The filing does not disclose any financial metrics or performance data.
- · Record date for eligibility to vote: July 17, 2026
- · Remote e-voting period: July 20, 2026 (9:00 AM IST) to July 23, 2026 (5:00 PM IST)
- · Meeting is NCLT-directed in connection with a proposed Scheme of Amalgamation
- · Notice and explanatory statement available on company website www.ekamleasing.in
07-07-2026
The President of India, acting through the Ministry of Ports, Shipping and Waterways, has exercised the Oversubscription Option in the offer for sale (OFS) of equity shares of Cochin Shipyard Limited, increasing the total offer size from a base of 66,29,636 shares (2.52% of paid-up capital) to up to 1,32,59,272 shares (5.04% of paid-up capital). The OFS will be executed via the stock exchange mechanism on July 7-8, 2026, with 10% reserved for retail investors and 26,308 shares (0.20% of the offer) reserved for eligible employees, subject to a maximum bid of ₹500,000 per employee.
- · The Oversubscription Option was exercised to the full extent of 66,29,636 shares, doubling the base offer.
- · Retail investors can participate on T+1 day (July 8, 2026) with 10% of the offer reserved for them.
- · Eligible employees may bid up to ₹500,000, but only ₹200,000 is considered for allocation in the first instance.
- · The OFS is conducted under SEBI circulars via separate designated windows on BSE and NSE.
07-07-2026
Arvind Limited's subsidiary, Arvind Atelier FZC (Sharjah, UAE), has acquired 100% of Arvind Atelier UK Limited for a cash consideration of £1,000 (One Thousand Pounds). The UK entity was incorporated on March 26, 2026, and has no material turnover or financial history. This acquisition makes Arvind Atelier UK Limited a step-down subsidiary of Arvind Limited, aimed at supporting the Group's international business objectives and strengthening its presence in the UK market.
- · The acquisition was completed on July 6, 2026, with information received by the company at 07:33 PM IST.
- · The acquisition does not fall under related party transactions.
- · No governmental or regulatory approvals were required for the acquisition.
- · The acquired entity operates in the Textiles - Garmenting industry.
- · The acquisition is intended to facilitate closer oversight of UK operations.
07-07-2026
Uno Minda Limited's Investment, Mergers & Acquisitions Committee approved a greenfield manufacturing facility for 4W Passenger Vehicle Seating Systems under its subsidiary/joint venture Uno Minda Tachi-S Seating Pvt. Ltd. (UMTS) with a total project cost of Rs. 320.00 Crore. The committee also approved further equity investment of up to Rs. 93.00 Crore in UMTS. The new facility will add 2,40,000 units per annum capacity, with SOP targeted for Q4 FY 2027-28 and phased completion by FY 2030-31. While the investment signals growth, UMTS's turnover has been modest (Rs. 23.39 Crore in FY 2025-26) and the project will take several years to contribute meaningfully.
- · The facility will be executed under UMTS, a subsidiary and joint venture with Tachi-S Company Ltd., Japan.
- · Existing capacity for this product line is nil; current capacity utilization is nil.
- · The investment will be financed through equity and term loan.
- · Rationale for capacity addition: business growth and to meet customer demand.
- · The further equity investment of up to Rs. 93.00 Crore will be made in one or more tranches, proportionate to current shareholding (Uno Minda holds 51%), so no change in control.
- · UMTS was incorporated on October 31, 2022, and operates only in India.
- · No prior governmental or regulatory approval is required for the acquisition.
- · The committee meeting started at 5:10 PM and ended at 5:35 PM on July 7, 2026.
07-07-2026
SEBI has issued a notice of attachment of demat account and mutual fund folios against Narendrabhai Amin in connection with Recovery Certificate No. 8484 of 2024, related to the matter of M/s Austral Coke and Projects Limited -II. This enforcement action indicates ongoing recovery proceedings by the regulator.
- · Recovery Certificate No. 8484 of 2024 is the basis for the attachment order.
- · The notice specifically targets demat account and mutual fund folio(s) of the individual.
- · The filing is categorized under SEBI's Recovery Proceedings enforcement section.
07-07-2026
SEBI has issued a notice of attachment for recovery against Narendrabhai Amin in connection with Recovery Certificate No. 8484 of 2024, related to M/s Austral Coke and Projects Limited -II. The filing indicates ongoing enforcement and recovery proceedings by the regulator.
- · Recovery Certificate No. 8484 of 2024 is the basis for the attachment notice.
- · The filing is categorized under SEBI's Recovery Proceedings enforcement section.
07-07-2026
SEBI issued an adjudication order on July 7, 2026, regarding insider trading activities in the scrip of RHI Magnesita India Ltd. The order details penalties or actions taken against parties involved in the insider trading case.
- · The filing is an adjudication order from SEBI's Enforcement division.
- · The order specifically addresses insider trading activities in the scrip of RHI Magnesita India Ltd.
07-07-2026
JB Chemicals & Pharmaceuticals Limited has received the certified copy of the National Company Law Tribunal (NCLT) order dated July 6, 2026, sanctioning the Scheme of Amalgamation of JB Chemicals with Torrent Pharmaceuticals Limited. The order was received on July 7, 2026, and is available on the company's website. This marks a key regulatory milestone in the merger process, though no financial terms or operational impacts are disclosed in this filing.
- · The NCLT order was passed on July 6, 2026, and the certified copy was received on July 7, 2026.
- · The scheme is under Sections 230 to 232 of the Companies Act, 2013.
- · The order is available on the company's website at www.jbpharma.com.
07-07-2026
07-07-2026
Torrent Pharmaceuticals Limited has received the certified copy of the National Company Law Tribunal (NCLT) Ahmedabad Bench order dated July 6, 2026, sanctioning the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited. The order was received on July 7, 2026, and is available on the company's website. This marks a key regulatory milestone in the merger process, though no financial details or performance metrics are disclosed in this filing.
- · The NCLT Ahmedabad Bench order was dated July 6, 2026.
- · The certified copy was received on July 7, 2026.
- · The scheme is under Sections 230 to 232 of the Companies Act, 2013.
- · The order is available on Torrent Pharma's website at www.torrentpharma.com.
07-07-2026
DS Kulkarni Developers Ltd has approved the acquisition of 100% equity of Moonbrick Realty Private Limited for nil consideration, as Moonbrick is a newly incorporated entity with no business operations. The board also appointed CS Rishika Verma as Company Secretary & Compliance Officer. The acquisition is a related party transaction due to common promoters but is stated to be at arm's length.
- · Moonbrick Realty Private Limited was incorporated on February 19, 2026, and has not commenced business operations.
- · The acquisition is proposed to be completed within one week.
- · No governmental or regulatory approvals are required for the acquisition.
- · CS Rishika Verma has 5 years of post-qualification experience as a company secretary & compliance officer of listed companies.
07-07-2026
Religare Enterprises Limited (REL) has received 'no objection' observation letters from NSE and BSE regarding its proposed Scheme of Arrangement with Religare Finvest Limited (RFL). The stock exchanges have conveyed no objection subject to compliance with numerous conditions, including detailed disclosures to shareholders, adherence to SEBI circulars, and listing requirements for RFL. The scheme remains subject to statutory approvals and shareholder/creditor consent, with the observation letter valid for six months from July 7, 2026.
- · The observation letters were received on July 07, 2026 from both NSE and BSE.
- · NSE's observation letter includes 18 specific conditions (a through r) that REL must comply with.
- · The scheme must be submitted to NCLT within six months from July 07, 2026 (validity of observation letter).
- · Listing of RFL shares is at the discretion of the exchange and subject to SEBI approval and additional conditions, including submission of an Information Memorandum and publication of newspaper advertisements.
- · Shares allotted under the scheme must remain frozen in the depository system until listing/trading permission is granted.
- · RFL must complete listing and commence trading within 60 days of receipt of the NCLT order.
- · The company must disclose the no-objection letter on its website within 24 hours of receipt.
- · The filing does not contain any financial figures or period-over-period comparisons.
07-07-2026
07-07-2026
POCL Enterprises Ltd has received a 'No adverse observation' letter from BSE Limited dated July 7, 2026, regarding its proposed Scheme of Amalgamation with Planetfirst Green Private Limited. The observation letter, valid for six months, includes 17 compliance conditions from SEBI, such as disclosure of pending adjudication proceedings, financials not older than six months, and mandatory demat issuance of shares. The scheme remains subject to further statutory and shareholder approvals.
- · The observation letter was issued under Regulation 37 of the SEBI (LODR) Regulations, 2015.
- · The scheme must be submitted to NCLT within six months from July 7, 2026.
- · SEBI's comments include 17 specific conditions covering disclosures, financials, share swap ratio, and pending actions.
- · The exchange reserves the right to withdraw its 'No adverse observation' if information is found incomplete or misleading.
- · The scheme involves amalgamation of an unlisted company (Planetfirst Green Private Limited) into a listed entity.
07-07-2026
Hira Automobiles Ltd. is currently unable to complete a delisting process that began in 2013, after a shareholder failed to provide the requisite consent in August 2014. In April 2024, SEBI imposed a penalty of ₹14 Lacs for non-filing of quarterly compliance reports, which the company has paid. The company is now seeking directions from SEBI to enable the promoters to comply with minimum public shareholding norms, indicating a protracted regulatory non-compliance spanning over a decade.
- · The delisting process was initiated on May 25, 2013, when Chairman Rahul Inder Singh Sidhu sent a request to public shareholders.
- · The company received in-principal approval from BSE, Ahmedabad Stock Exchange, and Delhi Stock Exchange on March 25, 2014, and from Ludhiana Stock Exchange on February 11, 2014.
- · The requisite consent from the shareholder was not received by August 14, 2014, halting the delisting.
- · SEBI's adjudication order dated April 16, 2024 imposed a penalty of ₹14 Lacs, which was paid on May 24, 2024.
- · The company states it is in the process of filing an application with SEBI to seek directions for the promoters to comply with minimum public shareholding norms.
07-07-2026
Winro Commercial (India) Ltd. has invested ₹99,99,97,380 (₹99,99,97,380) to acquire 3,46,860 equity shares of Adani Enterprises Ltd. at ₹2,883 per share under the QIB category in Adani Enterprises' QIP issue of ₹15,000 Crore. The investment, made on July 7, 2026, is part of Winro's normal course of business as an NBFC and exceeds 2% of its net worth, triggering disclosure requirements. Adani Enterprises reported consolidated turnover of ₹1,02,943.24 Crore for FY2026, up from ₹1,00,365.08 Crore in FY2025 and ₹98,281.51 Crore in FY2024, showing steady growth.
- · The investment exceeds 2% of Winro Commercial's net worth, triggering mandatory disclosure under SEBI LODR Regulation 30.
- · Adani Enterprises' authorized capital is ₹9,90,43,00,000 and paid-up capital is ₹1,30,16,93,464.
- · The acquisition is not a related party transaction and is done at arm's length.
- · Completion of the acquisition is expected on or before July 10, 2026.
- · Adani Enterprises has a diversified business portfolio including airports, roads, water management, data centers, solar manufacturing, defence, aerospace, edible oils, foods, mining, and integrated agri products.
07-07-2026
Promoter Westpac Investments Limited acquired 2,40,000 equity shares of Getalong Enterprise Ltd. on July 7, 2026, at ₹7.56 per share via open market purchases, increasing its stake from 41.94% to 43.07%. The total consideration for the acquisition was approximately ₹18,14,400. The filing also includes a concurrent insider trading disclosure under SEBI PIT Regulations.
- · The acquisition was executed in two trades: 5,000 shares and 2,35,000 shares, both at ₹7.56 per share.
- · The company's total equity share capital is ₹2,11,60,000 divided into 2,11,60,000 equity shares of ₹1 each.
- · The filing also serves as a disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (Form C).
- · Westpac Investments Limited is categorized as a promoter of Getalong Enterprise Limited.
07-07-2026
PVP Ventures Limited has completed the second tranche of its acquisition in 7 Med India Private Limited, acquiring an additional 4,263 equity shares to increase its stake to 41.23%. The total outlay for the majority shareholding (50.62%) is approximately INR 127 Crore, with the balance acquisition expected to be completed per the definitive agreements. This strategic investment expands PVP Ventures' presence in the healthcare sector, specifically in renal care services.
- · 7 Med India is among the top five organized players in India's renal care sector, offering a comprehensive range of dialysis services across a pan-India network.
- · The acquisition is not a related party transaction and is on an arm's length basis.
- · The first tranche of the acquisition was completed on 4th November 2025, making 7 Med India an associate company.
- · The transaction involves a combination of primary and secondary stake purchase.
- · No governmental or regulatory approvals were required for this acquisition.
07-07-2026
Desi Farms India Limited (formerly SER Industries Ltd) has acquired a 73.66% stake in SNA Milk and Milk Products Limited and a 62.67% stake in DFSU Farmer Connect Private Limited via a share swap, issuing 36,56,494 5% compulsorily convertible debentures. The total cost of acquisition is approximately ₹49.36 Crore. The acquisition is a related-party transaction and is part of the company's strategic expansion into the dairy and food products sector, while its existing logistics business remains unaffected.
- · The acquisition is a related-party transaction as SNA and DFSU are related parties within the meaning of Section 2(76) of the Companies Act, 2013, and Sunil Kumar Shahi (promoter/promoter group) is a director/shareholder of the target entities.
- · The transaction is executed at arm's length based on a valuation report from a Registered Valuer.
- · SNA Milk and Milk Products Limited was incorporated on 27th May 2016 and has a presence in Mumbai, Pune, Bangalore, Ahmedabad, Hyderabad, and other tier-1 cities.
- · DFSU Farmer Connect Private Limited was incorporated on 27th August 2025 and is engaged in ice cream, healthy snacks, and allied food products.
- · The company is in the process of acquiring 100% of SNA and DFSU within the prescribed time period pursuant to BSE in-principle approval dated 24th June 2026.
- · The company's existing logistics business remains unaffected by the acquisition.
07-07-2026
Compuage Infocom Limited, under Corporate Insolvency Resolution Process (CIRP), held its 26th Committee of Creditors (CoC) meeting on June 24, 2026, with e-voting concluding on July 7, 2026. The CoC approved several resolutions including the registration cost for a warehouse agreement with M/s Ashwamedh Express Pvt Ltd, ratification of annual listing fees for FY 2026-2027 paid to BSE and NSE, and settlements proposed by three debtors (M/s Infiniti Power Private Limited, M/s Alphatech Systems, and M/s Educare Technologies). However, the resolution to file an application before the NCLT for distribution of funds lying in the CIRP account and Indian Bank account did not receive the requisite voting and was not approved.
- · The 26th CoC meeting was held on June 24, 2026, with e-voting concluding on July 7, 2026.
- · Resolution Item 07 (filing application for distribution of funds from CIRP and Indian Bank accounts) was not approved due to insufficient voting.
- · Resolution Items 08, 09, 10A, 10B, and 10C were all approved via e-voting.
- · The company has been under CIRP since the NCLT order dated April 29, 2024.
07-07-2026
Chambal Breweries & Distilleries Limited reported audited financial results for the quarter ended June 30, 2026, with a net loss of ₹4.68 Lakhs, compared to a loss of ₹19.44 Lakhs in the year-ended March 2026, showing improvement. The Board also approved a scheme of amalgamation with Invade Agro Limited (the Transferee Company), which holds 22.93% of Chambal's equity, under an exchange ratio of 5 shares of Invade Agro for every 2 shares of Chambal. However, the company continues to report zero revenue from operations and negative net worth of ₹664.02 Lakhs in other equity, indicating ongoing financial distress.
- · The appointed date for the amalgamation is July 01, 2026.
- · The exchange ratio is 5 equity shares of Invade Agro (face value ₹10 each) for every 2 equity shares of Chambal (face value ₹10 each).
- · Chambal reported zero revenue from operations for both the quarter ended June 30, 2026 and the year ended March 31, 2026.
- · Total expenses for the quarter were ₹5.83 Lakhs, down from ₹23.22 Lakhs for the year ended March 31, 2026.
- · Cash and cash equivalents stood at ₹14.94 Lakhs as on June 30, 2026, compared to nil as on March 31, 2026.
- · Total assets decreased to ₹86.07 Lakhs from ₹94.04 Lakhs as on March 31, 2026.
- · The company's net worth (equity) was ₹84.85 Lakhs as on June 30, 2026, down from ₹92.59 Lakhs as on March 31, 2026.
- · The scheme is subject to approvals from shareholders, creditors, and the National Company Law Tribunal (NCLT).
07-07-2026
Kkalpana Plastick Limited has informed the exchange that its existing promoters, Bbigplas Poly Private Limited and Mrs. Sarla Surana, have entered into a Share Purchase Agreement (SPA) with Mr. Ashish Begwani to sell 40,12,335 equity shares (72.58% of paid-up capital) for an undisclosed consideration. This triggers a mandatory open offer under SEBI SAST Regulations for an additional 14,37,420 shares (26% of capital) at ₹28 per share in cash. Upon completion, Mr. Begwani will become the sole promoter, and the existing promoters will be reclassified as non-promoters, resulting in a complete change in control and management.
- · The open offer price is ₹28 per equity share, payable in cash.
- · The acquirer, Mr. Ashish Begwani, has no prior relationship with the company.
- · No nominee to the Board of Directors has been identified at this stage.
- · The transaction is subject to compliance with SEBI SAST Regulations, LODR, SCRR, Companies Act 2013, and other applicable laws.
- · The sellers (existing promoters) will be reclassified as non-promoters under Regulation 31A(10) of Listing Regulations upon completion.
07-07-2026
Epigral Limited has incorporated a wholly owned subsidiary named Epigral Advanced Materials Limited on July 7, 2026, with an objective to manufacture chemicals. The subsidiary has a paid-up capital of ₹1,00,000 (10,000 equity shares of ₹10 each) and is 100% held by Epigral Limited. No financial performance or further business details were disclosed.
- · The incorporation was notified under Regulation 30 of SEBI Listing Regulations with a certificate of incorporation received on July 7, 2026.
- · The subsidiary is classified as a related party of Epigral Limited and is in the chemicals industry.
07-07-2026
Tilaknagar Industries Limited has completed a further investment of ₹2 Crore in Round the Cocktails Private Limited (Bartisans) by subscribing to 1,569 Compulsory Convertible Preference Shares (CCPS) at ₹12,752 per share. The investment was disbursed on July 07, 2026, following a supplementary agreement dated June 26, 2026. No negative or flat performance metrics are present in this filing.
- · The investment was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- · The original agreements (share subscription, shareholders, and share purchase) were all dated September 19, 2024.
- · The supplementary agreement was entered into on June 26, 2026.
- · The disclosure is available on the company's website www.tilind.com.
07-07-2026
Constitution Capital Access Fund, LLC launched an issuer tender offer to repurchase up to 5.00% of its net assets (approximately $39.5M or 3,218,235 Shares) from shareholders. The offer expires on August 3, 2026, with the net asset value calculated as of August 31, 2026. Shareholders may tender all or some of their Class A, Class D, or Class I shares, but a 2.00% early repurchase fee applies to shares held less than one year, and a minimum $10,000 account balance must be maintained after partial tenders.
- · The Fund is a closed-end, non-diversified management investment company organized as a Delaware LLC.
- · There is no established trading market for the Shares; transfers are strictly limited by the LLC Agreement.
- · The Offer is not conditioned on any minimum number of Shares being tendered.
- · Shareholders may withdraw tenders at any time before the Notice Due Date (August 3, 2026) and also until August 31, 2026 if the Fund has not yet accepted the tender.
- · The Fund may cancel, amend, or postpone the Offer at any time before the Notice Due Date.
- · The Promissory Note is non-interest bearing and non-transferable; the Initial Payment (at least 90% of estimated value) is made within 65 days after the Notice Due Date, and the Final Payment follows the annual audit (expected by end of May 2027).
- · Net asset value per share as of May 31, 2026: Class A $12.25, Class D $12.25, Class I $12.27.
07-07-2026
Four Leaf Acquisition Corp (FORLW) announced a comprehensive governance restructuring, with the resignation of three directors (Alvin Wang, Stephen Markscheid, Rahul Mewawalla) and CFO Coco Kou, effective July 7, 2026. The company appointed Nanuk Warman, Jay Izso, and Mark DiSabato as independent directors, and Greg McCraw as the new CFO. The resignations were not due to any disagreements with the company.
- · The company moved its headquarters to 600 Park Offices Drive, Suite 300-4133, Durham, NC 27713 and updated its telephone number to 919-526-1070.
- · Nanuk Warman is CFO of CitroTech, Inc. (NYSE: CITR) and holds CPA and CFA designations.
- · Mark DiSabato has over 22 years of experience in governance, risk, and compliance including roles at National Bank of Egypt, Citi, Deutsche Bank, and Shutterstock.
- · Greg McCraw has served as CFO of Data443 Data Risk Mitigation, Inc. since September 2022.
07-07-2026
Nuvalent, Inc. is being acquired by a subsidiary of GSK plc for $124.00 per share in cash, implying a fully-diluted equity value of approximately $10.3 billion. The company received 11 demand letters from stockholders challenging disclosures in the initial Schedule 14D-9, which it denies as meritless but is voluntarily supplementing to avoid deal delays. The supplemental disclosures provide additional details on the background of the offer, including a non-binding proposal from GSK on May 12, 2026 at $120.00 per share, and expand on the financial analyses performed by Centerview, which showed implied equity values per share ranging from $74.50 to $149.05 depending on the methodology.
- · The Company received 11 demand letters from purported stockholders challenging disclosures in the initial Schedule 14D-9.
- · The Company denies the allegations and believes the claims are without merit, but is voluntarily supplementing disclosures to avoid delay and costs.
- · No officers or directors had discussions with GSK representatives regarding specific terms of post-closing employment.
- · Centerview's selected public company analysis implied equity value per share range of $74.50 to $131.95.
- · Centerview's precedent transactions analysis implied equity value per share range of $83.20 to $149.05.
- · Centerview's discounted cash flow analysis implied equity value per share range of $106.15 to $125.55.
- · Analyst price targets ranged from $116.00 to $172.00 per share as of June 8, 2026.
- · The offer price of $124.00 falls within the DCF range but below the analyst low target and the precedent transactions median.
07-07-2026
Osprey Acquisition Corp. III, a blank check company, priced its $261 million initial public offering of 26.1 million units at $10.00 per unit, with units trading on Nasdaq under the symbol OSPRU starting July 1, 2026. The SPAC will focus on acquiring companies deploying disruptive technologies in energy systems, AI-driven optimization, and sustainable infrastructure. The offering is led by Cantor Fitzgerald & Co., with a 45-day over-allotment option for up to 3.915 million additional units.
- · The Company is a blank check company formed for the purpose of effecting a merger or similar business combination.
- · Primary focus is on companies deploying disruptive technologies in energy systems, AI-driven optimization, and sustainable infrastructure.
- · Units will begin trading on July 1, 2026 under the symbol OSPRU.
- · Class A ordinary shares and warrants are expected to trade separately under symbols OSPR and OSPRW, respectively.
- · Closing of the offering is anticipated on or about July 2, 2026.
- · No fractional warrants will be issued; only whole warrants will trade.
07-07-2026
MacroGenics completed the sale of its GMP drug substance manufacturing operations to Bora Pharmaceuticals for $122.5 million in cash, before transaction fees and expenses. The deal includes the transfer of facilities in Rockville and Frederick, Maryland, and approximately 140 former MacroGenics employees hired by Bora. MacroGenics has entered into a supply agreement with Bora to support its internal pipeline needs, but the company remains a clinical-stage biopharmaceutical firm with no mention of immediate revenue growth from this transaction.
- · MacroGenics' manufacturing site in Rockville, Maryland, and warehouse in Frederick, Maryland, have been transferred to Bora.
- · MacroGenics entered into a supply agreement with Bora for process development and drug substance production for its internal pipeline.
- · Moelis & Company LLC served as exclusive financial advisor to MacroGenics; Sidley Austin LLP and Covington & Burling served as legal counsel.
- · Jones Day served as legal counsel to Bora.
- · The filing includes cautionary forward-looking statements regarding risks related to post-closing manufacturing arrangements and the possibility that additional post-closing cash payments may not be earned or received.
07-07-2026
On July 7, 2026, GSK plc, via its subsidiaries, filed an amendment to its tender offer statement for Nuvalent, Inc., offering $124.00 per share (Class A and Class B common stock). The HSR Act waiting period is set to expire July 9, 2026, but could be extended if a Second Request is issued. Additionally, the Company has received 11 demand letters from purported stockholders challenging certain disclosures, though no lawsuits have been filed as of the filing date.
- · The HSR Act waiting period expires at 11:59 PM Eastern Time on July 9, 2026, unless earlier terminated.
- · If a Second Request is issued, the waiting period extends by an additional 10 calendar days after substantial compliance.
- · One demand letter attached a draft complaint; no lawsuits filed as of July 7, 2026.
- · CUSIP for Class A Common Stock: 670703107.
- · Par value per share: $0.0001 for both Class A and Class B.
07-07-2026
Osprey Acquisition Sponsor III LLC and its affiliates filed a Schedule 13D disclosing beneficial ownership of 10,740,000 shares (26.18%) of Osprey Acquisition Corp. III, a blank-check company. The sponsor acquired 486,000 placement units for $4,860,000 in connection with the IPO that closed on July 2, 2026, and holds 10,254,000 founder shares. The filing outlines lock-up restrictions, voting agreements, and indemnification provisions typical for SPAC sponsors, with no recent transactions or plans for changes in control.
- · Sponsor paid $25,000 in offering costs on February 2, 2026.
- · Sponsor surrendered 25,000 founder shares in May 2026, reducing Class B shares from 10,279,000 to 10,254,000.
- · Placement units and underlying securities are subject to a 30-day lock-up after the initial business combination.
- · Sponsor has agreed to vote in favor of any proposed business combination and not to redeem shares.
- · Sponsor has agreed to indemnify the Issuer against certain claims to protect the trust account in case of liquidation.
- · No transactions in ordinary shares occurred during the 60 days prior to the filing date.
07-07-2026
SHOREPOWER TECHNOLOGIES INC. filed an 8-K on July 7, 2026, reporting the completion of an acquisition or disposition of assets (Item 2.01), along with unregistered sales of equity securities (Item 3.02), a change in control of the registrant (Item 5.01), and related director/officer departures and appointments (Item 5.02). No specific transaction details, financial metrics, or party names were disclosed in the summary, making it impossible to assess the financial impact or strategic rationale.
- · The filing includes Item 3.02 (unregistered equity sales), suggesting that equity was used as part of the transaction consideration.
- · Item 5.01 confirms a change in control, which would require disclosure of the new controlling shareholder(s) in the exhibit but not provided in the summary.
- · Item 5.02 indicates board and officer changes concurrent with the transaction.
07-07-2026
CareDx completed the sale of its Lab Products business to Eurobio Scientific for $171.2 million in cash, closing on June 30, 2026 after Swedish regulatory clearance. The divestiture sharpens CareDx's focus on its core U.S. Precision Medicine Testing Services and Patient & Digital Solutions, while simplifying its operating model and supporting capital allocation toward high-growth areas like specialty oncology. The company will provide further financial details, including pro forma results, during its Q2 2026 earnings call.
- · The transaction closed on June 30, 2026 following receipt of required Swedish regulatory clearance.
- · The sale includes CareDx's Lab Products business of IVD PCR kits for rapid deceased donor HLA typing, IVD NGS-based kits for transplant recipient HLA typing globally, and IVD NGS-based monitoring assays for solid organ and stem cell transplant recipients outside of North America.
- · CareDx is represented by Rothschild & Co. and Fenwick & West LLP; Eurobio Scientific is represented by TD Cowen and Kahn Partners.
- · The company anticipates providing additional details regarding the financial impact of the transaction, including pro forma results, during its second quarter 2026 earnings call.
07-07-2026
Viking Acquisition Corp. II, a blank check company, priced its initial public offering of 20,000,000 units at $10.00 per unit, raising $200,000,000. The units will trade on the NYSE under the ticker 'VII U' starting July 2, 2026. The offering is expected to close on July 6, 2026, with an underwriter option for an additional 3,000,000 units.
- · The underwriters (Cohen & Company Capital Markets) have a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.
- · Each whole warrant is exercisable at $11.50 per share, subject to adjustments.
- · The registration statement (Form S-1, File No. 333-296719) was declared effective by the SEC on June 30, 2026.
- · The Company is a blank check company formed to effect a merger or business combination, not limited to a specific industry or region.
07-07-2026
Banzai International filed an 8-K with audited financial statements of ConnectAndSell, Inc., a sales acceleration SaaS company, indicating a potential acquisition. ConnectAndSell's revenue declined 9.2% YoY to $14,715,954 in 2025, and net loss widened dramatically to ($3,111,468) from ($107,463) in 2024, primarily due to a $1,084,608 loss on debt extinguishment and higher interest expense. However, operating cash flow swung positive to $2,750,047 from ($1,946,151), and accounts receivable decreased by 53.0%. The company continues to operate with negative working capital, an accumulated deficit of $57,582,888, and a going concern opinion.
- · ConnectAndSell's operating expenses increased 1.2% YoY ($12,260,495 vs $12,119,817), with R&D and G&A up, but Sales & Marketing down.
- · Loss on debt extinguishment of $1,084,608 in 2025 (none in 2024) contributed to the net loss swing.
- · Line of credit balance decreased sharply from $2,052,593 to $207,648, while related party notes payable increased 34.6% to $4,057,046.
- · Internally developed software, net decreased 24.4% to $969,183, reflecting lower capitalization in 2025 ($438,101 vs $743,821 in 2024).
- · The company has a going concern opinion and is in negotiations to sell the company (Note 12).
07-07-2026
House of Doge Inc., the official corporate arm of the Dogecoin Foundation, completed its merger with Brag House Holdings, Inc. (formerly NASDAQ: TBH). The combined company is renamed House of Doge Inc. and will trade on Nasdaq under the new ticker symbol "HODO" as of July 1, 2026. Post-merger, House of Doge has approximately 75.9 million shares outstanding.
- · The merger was previously announced and closed on June 30, 2026.
- · The press release was issued on June 30, 2026, and filed with the SEC on July 7, 2026.
- · House of Doge gains direct access to U.S. capital markets to fund payments, digital asset treasury, real-world asset tokenization, and professional sports.
07-07-2026
The Glimpse Group, Inc. (NASDAQ: GGRP) announced the sale of its non-core legacy asset, Glimpse Learning, LLC, as part of a strategic transformation into a pureplay Physical AI infrastructure company. The company is now focusing on its Brightline Interactive subsidiary and its SpatialCore platform, which reduces integration timelines for autonomous systems from nearly a year to several weeks. The divestiture follows the appointment of CEO Tyler Gates, a new board chaired by Ret. Admiral Scott Swift, and a $1.85 million capital infusion earlier this year.
- · SpatialCore is an open standards-based interoperability and operational context platform for drones, robotics, autonomous vehicles, digital twins, and AI models.
- · The platform was designed in partnership with the US Navy and is used in live operations.
- · Brightline holds Cooperative Research and Development Agreements with both the U.S. Navy and U.S. Army.
- · The company's strategy is sequenced around deepening its footprint within the Department of War, extending into the defense-industrial base through OEM partnerships, and addressing the broader commercial autonomy market.
07-07-2026
Olaplex Holdings, Inc. received a delisting notice from Nasdaq effective July 7, 2026, citing compliance with 17 CFR 240.12d2-2(a)(3), which typically applies to securities that have been suspended from trading or for which the exchange has determined to delist. The company is no longer listed on Nasdaq, and its common stock will no longer trade on that exchange.
- · Filing effective date: July 7, 2026
- · Exchange: Nasdaq Stock Market LLC
- · Rule cited: 17 CFR 240.12d2-2(a)(3) — Delisting for failure to meet continued listing standards
- · SEC file number: 333-260016
Get daily alerts with 11 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →July 07, 2026
US Pre-Market SEC Filings Roundup — July 07, 2026
US Pre-Market SEC Filings Roundup
July 07, 2026
USA Insider Trading Pulse — July 07, 2026
USA Insider Trading Pulse
July 07, 2026
US Merger & Acquisition SEC Filings — July 07, 2026
US Merger & Acquisition SEC Filings
July 07, 2026
US Corporate Board Director Changes SEC Filings — July 07, 2026
US Corporate Board Director Changes SEC Filings